Germany
Japan
United Kingdom
China
Antibodies
Download
Mouse Monoclonal anti-CACNA1D Antibody
| Applications | IF |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) SILV mouse monoclonal antibody, clone OTI10E5 (formerly 10E5)
| Applications | IF, IHC, WB |
| Reactivities | Human, Monkey, Rat, Dog |
| Conjugation | Unconjugated |
USD 465.00
In Stock
USD 465.00
In Stock
USD 465.00
In Stock
Carrier-free (BSA/glycerol-free) POR mouse monoclonal antibody, clone OTI3F10 (formerly 3F10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) FCGR2A mouse monoclonal antibody, clone OTI13D7 (formerly 13D7)
| Applications | IF, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 465.00
In Stock
Carrier-free (BSA/glycerol-free) L1CAM mouse monoclonal antibody, clone OTI2A6 (formerly 2A6)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 465.00
In Stock
USD 465.00
In Stock
USD 465.00
In Stock
Carrier-free (BSA/glycerol-free) APP mouse monoclonal antibody, clone OTI4C3 (formerly 4C3)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 465.00
In Stock
Carrier-free (BSA/glycerol-free) NPR3 mouse monoclonal antibody, clone OTI4C3 (formerly 4C3)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
USD 465.00
In Stock
USD 465.00
In Stock
Active filters
Category
- Antibodies
Reactivities
- Human
Applications
- IF
Antibody Hosts
- Mouse
Clonalities
- Monoclonal
Conjugates
- Unconjugated
Families
- Transmembrane
Availabilities
- In Stock
Filter by
Target Symbol
- PDCD1 (57)
- KLK8 (40)
- ERBB2 (34)
- EPCAM (29)
- SYP (29)
- CD163 (27)
- PECAM1 (27)
- MLANA (25)
- L1CAM (22)
- CD1C (20)
- NPR3 (20)
- SPG7 (19)
- BSG (18)
- CD19 (17)
- LGR5 (17)
- PTPRE (16)
- APP (15)
- FATE1 (15)
- BTN1A1 (14)
- CYP1A2 (14)
- MCL1 (13)
- MUC1 (13)
- CD33 (12)
- FGFR2 (12)
- SYT4 (12)
- CD80 (11)
- ENG (11)
- FCGR2A (11)
- PDGFRB (11)
- RPN1 (11)
- BEST3 (10)
- CLDN6 (10)
- FCGR1A (10)
- GOLM1 (10)
- HP (10)
- PTPRC (10)
- RNF144B (10)
- SCAMP2 (10)
- CD274 (9)
- POR (9)
- SLC2A5 (9)
- SLC7A8 (9)
- BTLA (8)
- FA2H (8)
- KCNJ3 (8)
- MFAP3 (8)
- CD4 (7)
- EGFR (7)
- ENPEP (7)
- FOLH1 (7)
- NPTN (7)
- PCDH7 (7)
- ROMO1 (7)
- ROS1 (7)
- B3GNT2 (6)
- CA12 (6)
- CD36 (6)
- CD3E (6)
- CD44 (6)
- COX6A1 (6)
- CYBC1 (6)
- IL10RA (6)
- PMEL (6)
- PROM2 (6)
- PTPN1 (6)
- RET (6)
- SCARB1 (6)
- VCAM1 (6)
- CD5 (5)
- CISD1 (5)
- CYP2E1 (5)
- F11R (5)
- SIL1 (5)
- SPINT1 (5)
- CD2 (4)
- CD22 (4)
- CDCP1 (4)
- COX6C (4)
- FNDC4 (4)
- FXYD3 (4)
- GDAP1L1 (4)
- HMOX2 (4)
- ICAM3 (4)
- ILVBL (4)
- JPH2 (4)
- LMAN1 (4)
- MSMB (4)
- PDIA4 (4)
- PLAAT3 (4)
- PTK7 (4)
- SSR1 (4)
- TAPBPL (4)
- TFR2 (4)
- TMPRSS5 (4)
- TMX1 (4)
- TNF (4)
- VSIG2 (4)
- AQP1 (3)
- ASGR2 (3)
- BCL2L1 (3)
Knockout (KO) Validation
Pathways
- Cell adhesion molecules (CAMs) (192)
- Hematopoietic cell lineage (111)
- Pathways in cancer (87)
- T cell receptor signaling pathway (85)
- Prostate cancer (64)
- Focal adhesion (55)
- Adherens junction (54)
- Calcium signaling pathway (53)
- Leukocyte transendothelial migration (53)
- Metabolic pathways (52)
- Bladder cancer (45)
- Pancreatic cancer (44)
- Endometrial cancer (43)
- ErbB signaling pathway (41)
- Non-small cell lung cancer (41)
- MAPK signaling pathway (40)
- Primary immunodeficiency (40)
- Cytokine-cytokine receptor interaction (37)
- Systemic lupus erythematosus (36)
- Regulation of actin cytoskeleton (32)
- Fc gamma R-mediated phagocytosis (31)
- Alzheimer's disease (30)
- Endocytosis (30)
- Axon guidance (24)
- Drug metabolism - cytochrome P450 (22)
- Linoleic acid metabolism (22)
- Melanoma (22)
- B cell receptor signaling pathway (21)
- Gap junction (21)
- Colorectal cancer (20)
- Metabolism of xenobiotics by cytochrome P450 (19)
- Glioma (18)
- Tight junction (18)
- Caffeine metabolism (17)
- Retinol metabolism (17)
- Allograft rejection (15)
- Graft-versus-host disease (15)
- Toll-like receptor signaling pathway (15)
- Type I diabetes mellitus (15)
- Epithelial cell signaling in Helicobacter pylori infection (14)
- Tryptophan metabolism (14)
- Viral myocarditis (14)
- Parkinson's disease (13)
- Autoimmune thyroid disease (12)
- ECM-receptor interaction (12)
- Jak-STAT signaling pathway (12)
- Cardiac muscle contraction (11)
- N-Glycan biosynthesis (11)
- Adipocytokine signaling pathway (10)
- Huntington's disease (10)
- Oxidative phosphorylation (10)
- Arachidonic acid metabolism (8)
- GnRH signaling pathway (8)
- Thyroid cancer (8)
- Amyotrophic lateral sclerosis (ALS) (7)
- Antigen processing and presentation (7)
- Apoptosis (7)
- Dorso-ventral axis formation (7)
- Renin-angiotensin system (7)
- Basal cell carcinoma (6)
- Glycosphingolipid biosynthesis - lacto and neolacto series (6)
- Hedgehog signaling pathway (6)
- Insulin signaling pathway (6)
- Keratan sulfate biosynthesis (6)
- Natural killer cell mediated cytotoxicity (6)
- Nitrogen metabolism (6)
- PPAR signaling pathway (6)
- Dilated cardiomyopathy (5)
- Hypertrophic cardiomyopathy (HCM) (5)
- Neurotrophin signaling pathway (5)
- Type II diabetes mellitus (5)
- Asthma (4)
- Fc epsilon RI signaling pathway (4)
- NOD-like receptor signaling pathway (4)
- Porphyrin and chlorophyll metabolism (4)
- RIG-I-like receptor signaling pathway (4)
- TGF-beta signaling pathway (4)
- Vibrio cholerae infection (4)
- Amino sugar and nucleotide sugar metabolism (3)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (3)
- Chronic myeloid leukemia (3)
- Complement and coagulation cascades (3)
- Drug metabolism - other enzymes (3)
- Neuroactive ligand-receptor interaction (3)
- Small cell lung cancer (3)
- Pathogenic Escherichia coli infection (2)
- Renal cell carcinoma (2)
- SNARE interactions in vesicular transport (1)
- Vascular smooth muscle contraction (1)